146,630 Shares in CVS Health Co. (NYSE:CVS) Acquired by BSN CAPITAL PARTNERS Ltd

BSN CAPITAL PARTNERS Ltd purchased a new position in shares of CVS Health Co. (NYSE:CVS) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 146,630 shares of the pharmacy operator’s stock, valued at approximately $8,500,000. CVS Health comprises approximately 1.6% of BSN CAPITAL PARTNERS Ltd’s portfolio, making the stock its 27th largest holding.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health during the 4th quarter worth approximately $32,000. First Community Trust NA raised its position in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. Creekmur Asset Management LLC bought a new stake in CVS Health during the 4th quarter valued at $34,000. Steph & Co. raised its position in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. Finally, ORG Partners LLC raised its position in CVS Health by 11,840.0% during the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on CVS shares. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. Evercore ISI boosted their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $75.00.

CVS Health Price Performance

Shares of CVS Health stock opened at $65.96 on Thursday. The business has a 50 day simple moving average of $58.84 and a two-hundred day simple moving average of $61.20. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The stock has a market capitalization of $82.80 billion, a P/E ratio of 11.59, a PEG ratio of 0.81 and a beta of 0.54. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The business had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $2.21 earnings per share. As a group, analysts predict that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a $0.665 dividend. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.03%. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.